integrated statistical package stat view version 5.0 (SAS institute)
90
Structured Review
SAS institute
integrated statistical package stat view version 5.0
Integrated Statistical Package Stat View Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/integrated+statistical+package+stat+view+version+5%2E0/statview+5+0/pm37480334-147-9-14
Average 90 stars, based on 1 article reviews
Integrated Statistical Package Stat View Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/integrated+statistical+package+stat+view+version+5%2E0/statview+5+0/pm37480334-147-9-14
Average 90 stars, based on 1 article reviews
integrated statistical package stat view version 5.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study. Article Snippet: Enarodustat (JTZ-951) is an oral hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of anemia with chronic kidney disease.. Carcinogenicity of enarodustat was evaluated in a 26-week repeated oral dose study in Transgenic rasH2 (Tg.rasH2) mice and a 2-year repeated oral dose study in Sprague-Dawley (SD) rats.. The highest dose levels were set at 6 mg/kg in the Tg.rasH2 mouse study and at 1 mg/kg in the SD rat study based on the maximum tolerated doses in the 3-month and 6-month dose-range finding studies, respectively. |